Form D · Pharmaceuticals
Appello Pharmaceuticals, Inc.
Nashville, TN · CIK 0001745654
Offering snapshot reported Jan 24, 2022 · SEC filing
- Reported sold
- $13.5M Offering amount: $13.5M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Jan 13, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 24, 2022 | Initial | $13,500,014 | No comparison | 9 | SEC filing |
| Nov 30, 2020 | Amendment | $15,507,572 | $11,000,000vs Jul 10, 2018 | 5 | SEC filing |
| Jul 10, 2018 | Initial | $4,507,572 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-430564
Source: Form D, filed Jan 24, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vaughn Bryson | Director |
| Jeff P. Conn | Director |
| Joseph Cook, Jr. | Director |
| Howard Furst | Director |
| Howie Furst | Director |
| Brian Laden | Director, Executive |
| Christopher Rand | Executive |
| William Slattery | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3835 Cleghorn Ave #200
Nashville, TN, 37215
Nashville, TN, 37215